Skip to main content
Top
Literature
1.
go back to reference Roxburgh RH, Marquis-Nicholson R, Ashton F et al (2013) The p.Ala510Val mutation in the SPG7 (paraplegin) gene is the most common mutation causing adult onset neurogenetic disease in patients of British ancestry. J Neurol 260(5):1286–1294CrossRef Roxburgh RH, Marquis-Nicholson R, Ashton F et al (2013) The p.Ala510Val mutation in the SPG7 (paraplegin) gene is the most common mutation causing adult onset neurogenetic disease in patients of British ancestry. J Neurol 260(5):1286–1294CrossRef
2.
go back to reference Mihaylova P, Murphy S, Walsh R (2017) SPG7-related ataxia in the Irish National Ataxia clinic cohort. J Neurol Neurosurg Psychiatry 88(suppl 1):A1–A83 Mihaylova P, Murphy S, Walsh R (2017) SPG7-related ataxia in the Irish National Ataxia clinic cohort. J Neurol Neurosurg Psychiatry 88(suppl 1):A1–A83
3.
go back to reference Wedding IM, Koht J, Tran GT et al (2014) Spastic Paraplegia Type 7 Is Associated with Multiple Mitochondrial DNA Deletions. PLoS ONE 9(1):e86340 Wedding IM, Koht J, Tran GT et al (2014) Spastic Paraplegia Type 7 Is Associated with Multiple Mitochondrial DNA Deletions. PLoS ONE 9(1):e86340
Metadata
Title
Spastic paraplegia type 7 associated with a broad clinical phenotype
Authors
Luke Francis O’Donnell
Michael Hennessy
Publication date
01-11-2020
Publisher
Springer London
Published in
Irish Journal of Medical Science (1971 -) / Issue 4/2020
Print ISSN: 0021-1265
Electronic ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-020-02205-7

Other articles of this Issue 4/2020

Irish Journal of Medical Science (1971 -) 4/2020 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.